Dr. Essam Hamza reports

TREATMENT.COM AI INC. ENGAGES TAFIN GMBH FOR INVESTOR RELATIONS SERVICES

Treatment.com AI Inc. has engaged Tafin GmbH to provide investor relations services tailored to a German investor audience for an initial period of three months commencing on Jan. 17, 2025, in consideration of 150,000 euros.

Tafin shall utilize digital marketing and on-line advertisements through Google, Facebook and Instagram; third party newsletters; as well as other digital marketing on various third party websites. Tafin does not currently own any interest, directly or indirectly, in the company or its securities. Tafin's address is 65232 Taunusstein, Germany (phone: 49-6128-979-2946; e-mail: tafin@finanzmedien.gmbh). Tafin and its directors and officers are arm's length from the company.

About Treatment.com AI Inc.

Treatment.com AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively disrupt the health care sector and impact current inefficiencies and challenges. With the input of hundreds of health care professionals globally, Treatment.com AI has built a comprehensive, personalized health care AI engine, the Global Library of Medicine (GLM). Providing highly qualified clinical information and support to all health care professionals as well as providing recommended tests (physical and lab), X-rays and billing codes. The GLM helps health care professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and has the propensity for greater consistency in quality of patient support. Treatment's GLM platform also brings the possibility of health equity and inclusion for disenfranchised communities.

We seek Safe Harbor.